SCFAs have been reported to have beneficial effects such as improving glucose tolerance, suppressing obesity, inflammation, and cancer progression, and exerting immunostimulant effects through IgA production (4, 34–36). This evidence concerns the gene CD79A and obesity due to melanocortin 4 receptor deficiency.